This trigger stats point in time averages for this trigger type; 6:35a hibbett now sees fy22 eps of $11.70 to $11.90;factset consensus $11.41
Crdl) cardiol therapeutics stock price per share is $2.39 today (as of nov 12, 2021).
Crdl stock price nasdaq. According to the issued ratings of 2 analysts in the last year, the consensus rating for cardiol therapeutics stock is buy based on the current 2 buy ratings for crdl. (i.e., don't buy), and cut its price target on the stock more than 15% to $220 per share. What is cardiol therapeutics's market cap?
Date trigger direction signal return The company’s lead product, cardiolrx™, is a pharmaceutically produced oral cannabidiol formulation that is being investigated in a phase ii/iii outcomes study in. Cardiol therapeutics' (crdl) stock price has risen by 87 percent on a ytd basis due to several positive catalysts, including the listing on nasdaq.
Crdl ) cardiol therapeutics 's market cap is $129.70m , as of nov 14, 2021. Each unit will consist of one class a common share and 0.5 warrant. This suggests a possible upside of 229.9% from the stock's current price.
Their forecasts range from $5.00 to $8.00. A the stock price for cardiol therapeutics ( nasdaq : Today / last bid ask.
Cardiol therapeutics stock price prediction is an act of determining the future value of cardiol therapeutics shares using few different conventional methods such as eps estimation, analyst consensus, or fundamental intrinsic valuation. Crdl ) is $ 2.55 last updated today at 8:00:03 pm. (crdl) stock price quote with breaking news, financials, statistics, charts and more.
Current stock price for cardiol therapeutics (crdl)? Cardiol therapeutics (nasdaq:crdl) priced its public offering of 16.35m units at $3.07/unit for gross proceeds of ~$50.19m. On average, they anticipate cardiol therapeutics' stock price to reach $6.50 in the next year.
The average price target is $5.00, with a high forecast of $5.00 and a low forecast of $5.00. Primary metrics and data points about cardiol therapeutics inc. This price target is based on 2 analysts offering 12 month price targets for cardiol therapeutics in the last 3 months.
Crdl | complete cardiol therapeutics inc. The successful prediction of cardiol therapeutics' future price could yield a significant. Crdl) cardiol therapeutics's current earnings per share (eps) is n/a.
(crdl) stock quote, history, news and other vital information to help you with your stock trading and investing. Cardiol therapeutics to commence trading on nasdaq under the symbol crdl read full article. The average price target represents a 143.90% upside from the last price of $2.05.
Stock last trading day 1 week sensitivity effect score (1w) show on chart alpha trading signals for nasdaq:crdl. Find the latest cardiol therapeutics inc.
0 komentar:
Posting Komentar